Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered
coronavirus.
At this time, there are no specific vaccines or treatments for COVID-19. However, there are
many ongoing clinical trials evaluating potential treatments Drugs used to treat malaria
infection has shown to be beneficial for many other diseases, including viral infections.
In this Clinical trial, Investigators will evaluate the effect of Artemisinin / Artesunate on
morbidity of COVID-19 patients in decreasing the course of the disease and viral load in
symptomatic stable positive swab COVID-19 patients. Investigators are hypothesizing that due
to the antiviral properties of this drug it will help as a treatment for the COVID -19
patients. In improving their condition and clearing the virus load,